Dr. Lian is President and Chief Executive Officer of Viking Therapeutics. Previously, he was a Managing Director and Senior Research Analyst at SunTrust Robinson Humphrey, covering biotechnology companies.
Mr. Rowland has over 30 years of biopharmaceutical experience and previously served as President and CEO of Aurinia Pharmaceuticals, a clinical-stage company focused on lupus nephritis.
Geoffrey Barker, Ph.D., serves as Chief Development Officer at Viking Therapeutics. He has 30 years of experience in pharmaceutical and nonclinical development, including roles at Viking Therapeutics and Pyramid Laboratories.
Dr. Rouan has nearly 30 years of pharmaceutical industry experience, most recently serving as Senior Vice President and Head of Projects, Clinical Platforms and Sciences at GlaxoSmithKline.
Viking Therapeutics is located at 9920 Pacific Heights Blvd, Suite 500, San Diego, CA 92121. Contact information for investors, media, and business development is provided.
